Latest news
Take part in a lens implant trial
Posted: Thursday 4 January 2018
Magnifying telescopic lens implants, called intraocular telescopes, have been available privately for a number of years for late stage age-related macular degeneration (AMD).
Find out more
Top trustee role for Macular Society CEO
Posted: Monday 18 December 2017
The chief executive of the Macular Society Cathy Yelf has been appointed a trustee of the Association of Medical Research Charities (AMRC).The AMRC is a national membership organisation of leading medical and health research charities.The organisation ha…
Find out more
Petition delivered to Downing Street
Posted: Friday 15 December 2017
The Macular Society has delivered its petition to end needless sight loss to Number 10 Downing Street.The petition, which reached 11,000 signatures, was handed over by Macular Society volunteers Chris Thorley and Elaine Shaw.
Find out more
"I would have given up usage of any body part before my precious eyes"
Posted: Tuesday 5 December 2017
“2016 was one of the most stressful and saddest years of my life,” writes Gillian Ferguson from the Edinburgh Morningside Macular Support Group.
Find out more
Statins and AMD
Posted: Tuesday 28 November 2017
We know that some things which make age-related macular degeneration (AMD) more likely are also associated with cardiovascular diseases such as stroke and heart disease.
Find out more
Research priorities agreed to stop early age-related macular degeneration (AMD) turning into late AMD at Wellcome retreat
Posted: Tuesday 28 November 2017
Three leading sight loss charities, Blind Veterans UK, Fight for Sight and the Macular Society, have joined forces in the global fight against age-related macular degeneration (AMD).
Find out more
Images used to educate public about AMD not realistic, says study
Posted: Monday 27 November 2017
Images used to educate the public about vision loss due to the leading causes of blindness are not fit for purpose, according to a new study from City, University of London.The researchers found that the image commonly used to represent age-related macul…
Find out more
New drug could mean less frequent injections
Posted: Tuesday 21 November 2017
Results from a recent clinical trial suggest that a possible new treatment for wet age-related macular degeneration (AMD) could control symptoms as effectively as current treatments, with less frequent injections.The late-stage trials have revealed the d…
Find out more
Petition reaches more than 11,000 signatures
Posted: Monday 20 November 2017
More than 11,000 people signed our petition to end needless sight loss, after a Macular Society volunteer was forced to invade the headquarters of his local healthcare commissioners when he experienced delays to treatment.Chris Thorley waited more than n…
Find out more
Charles Bonnet Awareness Day
Posted: Tuesday 14 November 2017
As part of our Charles Bonnet campaign, which launched last month, we encouraged people to talk openly about their hallucinations.Today, to mark Charles Bonnet Awareness Day
Find out more
Coming up in winter’s Sideview
Posted: Tuesday 14 November 2017
The latest issue of Sideview magazine will be sent out to 22,000 Macular Society members in late November.
Find out more
FDA investigate potential Stargardt treatment
Posted: Monday 13 November 2017
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a drug to help treat Stargardt disease, according to Lin BioScience.The drug, known as LBS-008, is designed to prevent the build-up of a toxin in the eye called lipofuscin…
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter
